|
|
 |
 |
 |

The Translational Research Center at Kyoto University Hospital (hereafter TRC) was founded in October 2001 to develop
innovative medicine. The mission and goal of TRC are to accelerate therapeutics innovation and to improve therapeutic outcome of
intractable disorders.
TRC consists of three divisions, Department of Experimental Therapeutics, Department of Clinical Trial
Design & Management and Department of Clinical Innovative Medicine. Department of Trial Design & Management was established
in December 2001 to support clinical studies, focusing on protocol development and strategic clinical trials (Phase I to III).
Masanori Fukushima MD, PhD, Medical Oncologist, is the professor and chairman of this department.
|

(2008.4.1)
| Professor |
Masanori Fukushima, MD, PhD (Kyoto Univ.)
| Specialty: |
|
Medical Oncology |
|
|
Design & Management of Clinical Trial |
|
Associate Professor |
Satoshi Teramukai, PhD
| Specialty: |
|
Biostatistics |
|
|
Clinical Trial Methodology |
|
Satoshi Morita, PhD
|
Assistant Professor |
Harue Tada, MPH, RN
| Specialty: |
|
Pharmacoepidemiology |
|
|
Design & Management of Clinical Trial |
Keiichi Yamamoto
| Specialty: |
|
Medical Informatics |
|
|
|
Emiko Doi
| Specialty: |
|
Design & Management of Clinical Trial |
|
|
|
Rie Onodera, MS
| Specialty: |
|
Design & Management of Clinical Trial |
|
|
Regenarative Medicine |
Miyuki Niimi, PhD, RN
| Specialty: |
|
Clinical Trial Methodology |
|
|
Data Management |
Shiro Tanaka, PhD
|
Pharmacist |
|
Chihiro Suzuki |
Medical Technician |
|
Mihiro Sugiura |
Nurse |
|
Nanae Seo |
Researcher |
|
Yoko Teraguchi |
Technical Assistants |
Naoki Eguchi
Asakazu Ogasawara
Yukari Nishida |
Secretary |
|
Rika Shimoyama |
Graduate Students |
Miho Nagae, Pharmacist
Bin Zhou, MD
Tsutomu Nishimura, RN
Yusuke Kishida, MD
(Gastrointestinal Surgery)
Koya Hida, MD |
Research Students |
Keiko Murata, Pharmacist
Kotone Matsuyama, Pharmacist
Shinsuke Kojima, MD
Takashi Yamamoto, Pharmacist
|

(2006.4.1)
We take strategic approaches for
clinical development of new drugs and devices. Ongoing
Studies are as following table;
|
| Department of Trial Design & Management: Investigator-Sponsored Clinical Studies |
|
|
|
| No |
Study |
Type |
Investigator |
Institution |
Status |
| 1 |
Ghrelin |
Phase I |
Prof. Kangawa |
Kyoto Univ.,
TRC |
Closed |
| 2 |
Ghrelin for FD |
Phase II |
Prof. Kangawa |
Kyoto Univ.,
TRC |
Ongoing |
| 3 |
Ghrelin for OA |
Phase II |
Prof. Kangawa |
Kyoto Univ.,
TRC |
Ongoing |
| 4 |
HGF |
Phase I / II |
Prof. Tsubouchi |
Kyoto Univ.,
TRC |
Ongoing |
| 5 |
ONO-4819・CD for UC |
Phase II |
Prof. Narumiya |
Kyoto Univ.,
TRC |
Ongoing |
| 6 |
AMD |
Outcomes |
Assoc.Prof.
Takahashi |
Nationwide |
Ongoing |
| 7 |
UFT/GEM for NSCLC |
Phase I |
Prof. Wada |
Kyoto Univ. |
Closed |
| 8 |
BMCT for AMI |
Phase I / II |
Assoc.Prof.
Kimura |
Kyoto Univ. |
Ongoing |
| 9 |
bFGF for BB |
Phase I / II |
Prof. Komeda |
Kyoto Univ. |
Ongoing |
| 10 |
bFGF for PA |
Phase I / II |
Prof. Komeda |
Kyoto Univ. |
Ongoing |
| 11 |
Leptin for LADM |
Phase II |
Prof. Nakao |
Kyoto Univ. |
Ongoing |
| 12 |
HBV for LT |
Phase II |
Prof. Tanaka |
Kyoto Univ. |
Ongoing |
| 13 |
DST for LT |
Phase II |
Assoc.Prof.
Koshiba |
Kyoto Univ. |
Ongoing |
| 14 |
AM for PC |
Phase II |
Prof. Ogawa |
Kyoto Univ. |
Ongoing |
| 15 |
TCC/Cystectomy |
Outcomes |
Prof. Ogawa |
Nationwide |
Closed |
| 16 |
Lympho Edema |
Outcomes |
Assoc.Prof.
Sasaki |
Nationwide |
Closed |
| 17 |
Ovarian Ca. |
Outcomes |
Prof. Ochiai |
Nationwide |
Closed |
| 18 |
Suresample for Endometrial Ca. |
Outcomes |
Assoc.Prof.
Sasaki |
Tokyo Area |
Ongoing |
| 19 |
Lung Ca. |
Outcomes |
Prof. Wada |
Nationwide |
Closed |
| 20 |
CRT for LC |
Outcomes |
Prof. Mishima |
Nationwide |
Closed |
| 21 |
Renal Cell Ca. |
Outcomes |
Prof. Ogawa |
Nationwide |
Ongoing |
| 22 |
Renal Cell Ca. |
Outcomes |
Prof. Manabe |
Nationwide |
Ongoing |
|
|